Parkinson's Disease Trial, Recruiting NCT05854524 Sponsor: University of Nevada, Las Vegas Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05854524
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Parkinson's disease:

  • People aged between 30 and 85 years old
  • People who have been diagnosed with Parkinson's disease by a neurologist
  • People who are able to do 30 minutes of moderate aerobic exercise with 2 to 3 short breaks (based on self-report)

For people without Parkinson's disease (control group):

  • People aged between 30 and 85 years old
  • People without any major medical diagnoses
  • People who are able to do 30 minutes of moderate aerobic exercise with 2 to 3 short breaks (based on self-report)

Who may not be able to join:

  • People with a health condition that would prevent safe exercise participation, such as heart rhythm problems, uncontrolled blood pressure, or exercise-induced asthma (based on self-report)
  • People who are not cleared for exercise participation after completing a standard exercise readiness questionnaire (called the PAR-Q+), which checks for risk factors related to moderate physical activity
  • People with dementia, as the trial includes self-report questionnaires — this is assessed using a memory and thinking test called the Montreal Cognitive Assessment, and a score of 21 or below would mean a person is not eligible; people with mild cognitive impairment or no cognitive impairment are eligible to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Merrill Landers, DPT, PhD, University of Nevada, Las Vegas

Phone: 17028951377

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Nevada, Las Vegas
Registry
ClinicalTrials.gov
Start date
29 August 2024
Est. completion
30 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Exercise and inflammatory milieu; Inflammatory milieu comparison to controls; Exercise dose and biomarkers; Biomarkers in Parkinson Disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov